This general guidance remains applicable for patients taking GLP-1 medications
Ethiop J Sci Technol
Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease
For instance, Eli Lilly reported a 45% year-over-year revenue increase in Q4 2024, driven largely by its GLP-1 portfolio
As side effects resolve and eating becomes easier, ensuring adequate protein preserves muscle mass and supports continued fat loss
Seek help to talk out your worries safely